The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 14, 2023 | Bolno Paul | Director | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Coulie Bernard | Director | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Elia Marc | Director | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Garg Pushkal | Director | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Jensen Klavs F. | Director | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Schegerin Marc | Director | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Schulman Amy W | Director, 10% Owner | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Srivastava Sapna | Director | Grant(A) | 40K | — | $0 |
| Jun 14, 2023 | Vink Patrick V.J.J. | Director | Grant(A) | 40K | — | $0 |
| Jan 24, 2023 | Bernstein Howard PHD MD | Interim Chief Executive Office, Director | Grant(A) | 830K | — | $0 |
| Jan 24, 2023 | First David | Chief People Officer | Grant(A) | 200K | — | $0 |
| Jan 24, 2023 | Knopf Lawrence J | General Counsel | Grant(A) | 227K | — | $0 |
| Jan 24, 2023 | Warren Marshelle Smith | Chief Medical Officer | Grant(A) | 261K | — | $0 |
| Jan 24, 2023 | Capasso Richard | See Remarks | Grant(A) | 213K | — | $0 |
| Aug 15, 2022 | Capasso Richard | See Remarks | Sell(S) | 1K | $3.33 | $4K |
| Jul 11, 2022 | Zajic Micah | Chief Financial Officer | Grant(A) | 10K | — | $0 |
| Jun 30, 2022 | Capasso Richard | See Remarks | Grant(A) | 1K | $2.70 | $3K |
| Jun 30, 2022 | Knopf Lawrence J | General Counsel | Grant(A) | 1K | $2.70 | $4K |
| Jun 30, 2022 | Sharei Armon | President and CEO, Director | Grant(A) | 2K | $2.70 | $7K |
| Jun 15, 2022 | Schulman Amy W | Director, 10% Owner | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Garg Pushkal | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Bolno Paul | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Srivastava Sapna | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Jensen Klavs F. | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Schegerin Marc | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Elia Marc | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2022 | Coulie Bernard | Director | Grant(A) | 20K | — | $0 |
| Jun 1, 2022 | Warren Marshelle Smith | Chief Medical Officer | Grant(A) | 200K | — | $0 |
| May 25, 2022 | Jensen Klavs F. | Director | Buy(P) | 14K | $3.52 | $50K |
| Feb 10, 2022 | Zajic Micah | Chief Business Officer | Grant(A) | 80K | — | $0 |
| Feb 10, 2022 | First David | Chief People Officer | Grant(A) | 66K | — | $0 |
| Feb 10, 2022 | Capasso Richard | See Remarks | Grant(A) | 42K | — | $0 |
| Feb 10, 2022 | Knopf Lawrence J | General Counsel | Grant(A) | 97K | — | $0 |
| Feb 10, 2022 | Sharei Armon | President and CEO, Director | Grant(A) | 395K | — | $0 |
| Feb 10, 2022 | Bernstein Howard PHD MD | Chief Scientific Officer | Grant(A) | 195K | — | $0 |
| Jan 12, 2022 | Sharei Armon | President and CEO, Director | Option exercise(M) | 13K | $1.81 | $24K |
| Jan 12, 2022 | Sharei Armon | President and CEO, Director | Option exercise(M) | 13K | $1.81 | $24K |
| Dec 31, 2021 | Sharei Armon | President and CEO, Director | Grant(A) | 2K | $7.59 | $13K |
| Dec 31, 2021 | Knopf Lawrence J | General Counsel | Grant(A) | 454 | $7.59 | $3K |
| Dec 22, 2021 | Schulman Amy W | Director, 10% Owner | Option exercise(M) | 7K | — | $0 |
| Dec 22, 2021 | Schulman Amy W | Director, 10% Owner | Option exercise(M) | 7K | — | $0 |
| Dec 22, 2021 | Schulman Amy W | Director, 10% Owner | Option exercise(M) | 10K | — | $0 |
| Dec 22, 2021 | Schulman Amy W | Director, 10% Owner | Option exercise(M) | 7K | $4.59 | $34K |
| Dec 22, 2021 | Schulman Amy W | Director, 10% Owner | Option exercise(M) | 7K | $4.59 | $30K |
| Dec 22, 2021 | Schulman Amy W | Director, 10% Owner | Option exercise(M) | 10K | $2.02 | $20K |
| Dec 22, 2021 | Sharei Armon | President and CEO, Director | Option exercise(M) | 11K | — | $0 |
| Dec 22, 2021 | Sharei Armon | President and CEO, Director | Option exercise(M) | 11K | $1.81 | $20K |
| Dec 13, 2021 | Schulman Amy W | Director, 10% Owner | Buy(P) | 2K | $10.94 | $20K |
| Dec 13, 2021 | Schulman Amy W | Director, 10% Owner | Buy(P) | 2K | $10.88 | $20K |
| Jul 1, 2021 | Vink Patrick V.J.J. | Director | Grant(A) | 21K | — | $0 |
| Jul 1, 2021 | Coulie Bernard | Director | Grant(A) | 21K | — | $0 |
| Jun 15, 2021 | Elia Marc | Director | Grant(A) | 11K | — | $0 |
| Jun 15, 2021 | Schulman Amy W | Director, 10% Owner | Grant(A) | 11K | — | $0 |
| Jun 15, 2021 | Schegerin Marc | Director | Grant(A) | 11K | — | $0 |
| Jun 15, 2021 | Srivastava Sapna | Director | Grant(A) | 11K | — | $0 |
| Jun 15, 2021 | Garg Pushkal | Director | Grant(A) | 11K | — | $0 |
| Jun 15, 2021 | Jensen Klavs F. | Director | Grant(A) | 11K | — | $0 |
| Jun 15, 2021 | Bolno Paul | Director | Grant(A) | 11K | — | $0 |
| Oct 29, 2020 | Zajic Micah | Chief Business Officer | Grant(A) | 33K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).